Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
McCord Development Invests $30M in Biohub Two at Houston's Life Science Ecosystem
McCord Development is strengthening its presence in the life sciences and biomanufacturing sector with the launch of BioHub Two
ST Pharm Invests US$110 million to Open New Oligonucleotide Facility in South Korea
ST Pharm invests US$110 million to open new stateoftheart Oligonucleotide facility at Banwol campus, South Korea
Sandoz Unveils $90M Investment in Slovenian Biosimilar Development Center
Sandozs investment sets the stage for a significant transformation of the Ljubljana site into a central hub for advancing biosimilar products within the company
Biovian announces €50 Million Investment in State-of-the-Art Manufacturing Hub in Finland
Prominent contract development and manufacturing organization CDMO, Biovian Oy, known for its expertise in biopharmaceuticals, announces a significant upgrade to its Turku manufacturing facility
MilliporeSigma to Invest $25 Million in Expanding Cell Culture Media Production in Kansas
The expansion will involve the addition of 98,000 square feet of lab space and production capability specifically for manufacturing cell culture media
Aurigene Pharmaceutical Services Invests US$40 miilion to Contsruct New Biomanufacturing Facility
Aurigene Pharmaceutical Services a subsidiary of Dr Reddys Laboratories plans to invest US$40 million to construct new stateofthe art development and manufacturing facility in Hyderabad
Cytiva to Invest US$15.8 million to Expand Manufacturing Facility
Cytiva invests US$158 to expand its facility for manufacturing hightech medical instruments The facility will be located in Umea, Europe
Agilent Announces $22 Million Investment for Expansion of Newport Plant
Agilent, a leading global developer and manufacturer of analytical instrumentation, has announced its plans to invest in the expansion of its Newport production plant
OLON Invests €22 Million in New Facility, Ventures into the ADC Market
OLON, a global pharmaceutical leader, is constructing a new facility in Milan, Italy for the exclusive production of ultrapotent compounds, reinforcing its industry dominance in APIs
Merck's €35 Million Investment in Scotland Expands Global Commitment to Biosafety Testing
Merck Enhances Biosafety Testing Capabilities in Scotland at Glasgow and Stirling Sites with Groundbreaking Investment
